F. Hampel

发表

A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.

E. Bronsky, H. Druce, S. Findlay, 1995, The Journal of allergy and clinical immunology.

Early Bronchodilatory Effects of Budesonide/Formoterol pMDI Compared with Fluticasone/Salmeterol DPI and Albuterol pMDI: 2 Randomized Controlled Trials in Adults with Persistent Asthma Previously Treated with Inhaled Corticosteroids

F. Hampel, W. Mezzanotte, Paula Martin, 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study.

F. Hampel, L. Mendelson, A. Schaberg, 1996, Clinical therapeutics.

Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.

L. Mansfield, F. Hampel, P. Ratner, 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.

E. Meltzer, J. Bernstein, F. Hampel, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.

F. Hampel, P. Ratner, W. Howland, 1998, The Journal of family practice.

Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.

F. Hampel, P. Ratner, N. Amar, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Montelukast for treating seasonal allergic rhinitis: a randomized, double‐blind, placebo‐controlled trial performed in the spring

M. Malice, T. Reiss, F. Hampel, 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.

F. Hampel, C. Andrews, B. Prillaman, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies

F. Hampel, P. Ratner, C. Andrews, 2017, Allergy, Asthma & Clinical Immunology.

No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis.

F. Hampel, Jiang Li, C. Small, 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Efficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis.

R. Jacobs, F. Hampel, P. Ratner, 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Once-daily treatment with beclomethasone dipropionate nasal aerosol does not affect hypothalamic-pituitary-adrenal axis function.

S. Miller, F. Hampel, P. Ratner, 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis.

P. Dorinsky, F. Hampel, P. Ratner, 2012, Allergy and asthma proceedings.

Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria.

F. Hampel, P. Ratner, Jean-Marc C. Haeusler, 2010, Allergy and asthma proceedings.

Effectiveness of fluticasone furoate 110 μg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen*

R. Jacobs, F. Hampel, A. Ellsworth, 2009, Current medical research and opinion.

Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents.

Wei Wu, F. Hampel, P. Ratner, 2007, Allergy and asthma proceedings.

Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis.

F. Hampel, P. Ratner, T. Shah, 2006, The Journal of allergy and clinical immunology.

Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis.

F. Hampel, P. Ratner, T. Shah, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.

E. Meltzer, D. Bernstein, P. Roland, 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis

F. Hampel, C. Baidoo, K. Rickard, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis

G. Settipane, E. Meltzer, B. Prenner, 1996 .

Preseasonal, once daily triamcinolone acetonide nasal aerosol for seasonal allergic rhinitis.

F. Hampel, P. Ratner, G. Gross, 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily.

S. Findlay, F. Hampel, P. Ratner, 1992, The Journal of allergy and clinical immunology.

Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis.

R. Nathan, K. Nolop, R. Berkowitz, 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Intranasal fluticasone propionate is effective and well-tolerated in adolescents with seasonal allergic rhinitis

F. Hampel, D. Stempel, P. Rogenes, 1994 .

Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis.

S. Findlay, F. Hampel, P. Ratner, 1994, Archives of internal medicine.

Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group.

F. Hampel, J. Guerin, E. Lisberg, 2000, The Journal of asthma : official journal of the Association for the Care of Asthma.

Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.

F. Hampel, B. Kittner, J. V. van Bavel, 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.

F. Hampel, H. Milgrom, B. Kittner, 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.

F. Hampel, P. Ratner, W. Howland, 2004, Journal of investigational allergology & clinical immunology.

A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis.

S. Findlay, F. Hampel, P. Ratner, 1994, The Journal of allergy and clinical immunology.

Effectiveness of Low Doses (50 and 100 μg b.i.d.) of Beclomethasone Dipropionate Delivered as a CFC-Free Extrafine Aerosol in Adults with Mild to Moderate Asthma

F. Hampel, J. Guerin, E. Lisberg, 2000 .

ORIGINAL ARTICLES Effectiveness of Low Doses (50 and 100 pg b.i.d.) of Beclomethasone Dipropionate Delivered as a CFC-Free Extrafine Aerosol in Adults with Mild to Moderate Asthma

F. Hampel, E. Lisberg, 2000 .

Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications.

R. Dockhorn, D. Tinkelman, E. Bronsky, 1995, The Journal of allergy and clinical immunology.

The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects.

F. Hampel, P. Ratner, W. Howland, 1996, Clinical therapeutics.

Brompheniramine Maleate: A Double-Blind, Placebo-Controlled Comparison with Terfenadine for Symptoms of Allergic Rhinitis

H. Druce, F. Hampel, P. Ratner, 1998, American journal of rhinology.

A comparison of once-daily triamcinolone acetonide aqueous and twice-daily beclomethasone dipropionate aqueous nasal sprays in the treatment of seasonal allergic rhinitis.

J. Murray, W. Lumry, F. Hampel, 2003, Allergy and asthma proceedings.

A Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Ebastine 20 mg Once Daily Given with and without Food in the Treatment of Seasonal Allergic Rhinitis

F. Hampel, S. Rohatagi, M. Gillen, 2002, Journal of clinical pharmacology.

A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis.

R. Dockhorn, E. Meltzer, K. Nolop, 1999, The Journal of allergy and clinical immunology.

Efficacy and Safety of Levocabastine Nasal Spray for Seasonal Allergic Rhinitis

F. Hampel, S. Travers, B. Martin, 1999, American journal of rhinology.

Double-strength beclomethasone dipropionate (84 micrograms/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis.

G. Settipane, E. Meltzer, B. Prenner, 1996, The Journal of allergy and clinical immunology.

AR101 Oral Immunotherapy for Peanut Allergy

William H. Yang, N. Rupp, G. Toit, 2018, The New England journal of medicine.

Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.

F. Henderson, Julia H N Harris, F. Hampel, 2007, Clinical therapeutics.

Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.

F. Hampel, P. Ratner, N. Amar, 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Once-Daily Budesonide Inhalation Powder (Pulmicort Turbuhaler®) is Effective and Safe in Adults Previously Treated with Inhaled Corticosteroids

F. Hampel, M. Sugar, W. James Metzger, 2002, The Journal of asthma : official journal of the Association for the Care of Asthma.

Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.

F. Hampel, P. Ratner, N. Amar, 2006, Allergy and asthma proceedings.

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.

P. Roland, F. Hampel, P. Ratner, 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Once-daily budesonide inhalation powder (Pulmicort Turbuhaler®) improves health-related quality of life in adults previously receiving inhaled corticosteroids

B. Parasuraman, F. Hampel, B. Liljas, 2004, Advances in therapy.

Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.

Gurdyal Kalsi, F. Hampel, R. Hopkins, 2016, Vaccine.

Study of levocetirizine in seasonal allergic rhinitis

L. Mansfield, F. Hampel, Jean-Marc C. Haeusler, 2010, Current medical research and opinion.

Dose-dependent effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis (SAR)

F. Hampel, P. Ratner, T. Shah, 2004 .

Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis

J. Virchow, J. Bousquet, C. Bachert, 2013, International Archives of Allergy and Immunology.

Efficacy and safety of GSP301 nasal spray in children aged 6-11 with seasonal allergic rhinitis.

C. Caracta, B. Prenner, F. Hampel, 2022, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.

C. Caracta, R. Jacobs, F. Hampel, 2019, Allergy and asthma proceedings.

Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.

F. Hampel, B. Kittner, J. V. van Bavel, 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

S. Spector, J. Kemp, R. Nathan, 1998, The Journal of allergy and clinical immunology.

Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.

F. Hampel, P. Ratner, N. Amar, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Onset of efficacy of montelukast in seasonal allergic rhinitis.

M. Malice, T. Reiss, F. Hampel, 2005, Allergy and asthma proceedings.